EYEPOINT PHARMACEUTICALS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.84 USD | +11.07% |
|
-35.57% | -44.41% |
| 08/05 | Baird Adjusts Price Target on EyePoint Pharmaceuticals to $38 From $46, Keeps Outperform Rating | MT |
| 08/05 | Earnings Flash (EYPT) EYEPOINT PHARMACEUTICALS Posts Q1 Revenue $11.7M | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 16.16 | 29.71 | 28.80 |
| Spread/Res. | -20.50% | -56.76% | -55.39% |
| Spread/Supp. | +14.71% | +114.13% | +117.76% |
| Support | 11.20 | 6.000 | 5.900 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- EYPT Stock
- Charts EyePoint Pharmaceuticals, Inc.